Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
Molecular Pharmacology · 2023
DOI: 10.1124/molpharm.122.000587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmacology, 2023. Verfasst von Fan Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy (F.Y., C.L.), Minhang Hospital and School of Pharmacy, State Key Laboratory of Molecular Engineering o…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmacy (F.Y., C.L.), Minhang Hospital and School of Pharmacy, State Key Laboratory of Molecular Engineering of Polymers, Key Laboratory of Smart Drug Delivery Ministry of Educatio…
ORCID-Profile: Chenglong Liu
Zitieren
APA
Yang, F., Liu, C., Li, P., Wu, A., Ma-Lauer, Y., Zhang, H., Su, Z., Lu, W., von Brunn, A., & Zhu, D. (2023). Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation. Molecular Pharmacology. https://doi.org/10.1124/molpharm.122.000587
Vancouver
Yang F, Liu C, Li P, Wu A, Ma-Lauer Y, Zhang H, et al. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation. Molecular Pharmacology. 2023. doi:10.1124/molpharm.122.000587
BibTeX
@article{Yang2023,
author = {Yang, Fan and Liu, Chenglong and Li, Pengyuan and Wu, Aihua and Ma-Lauer, Yue and Zhang, Hao and Su, Zhuang and Lu, Wei and von Brunn, Albrecht and Zhu, Di},
title = {Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation},
journal = {Molecular Pharmacology},
year = {2023},
doi = {10.1124/molpharm.122.000587}
}
EUVIMED